Quality & complianceOfficial

Denmark flags supply problems for Nobilis Gumboro D78 poultry vaccine from MSD Animal Health

🇩🇰 DKMA · Tue 27 Oct 2026

The Danish Medicines Agency says production problems are disrupting supply of the live infectious bursal disease vaccine, with disruption expected from late September to mid-December 2026.

The Danish Medicines Agency (DKMA) has published a supply notice for Nobilis Gumboro D78 Vet., a veterinary vaccine marketed in Denmark by MSD Animal Health A/S. The notice is dated 27 October 2026 and reports current supply problems.

The product concerned is Nobilis Gumboro D78 Vet. 10,000 TCID50/dose, a powder for solution in drinking water. Its active substance is live infectious bursal disease virus, strain D78, and its ATC vet code is QI01AA01.

DKMA gives the cause as production problems. The expected period of disruption runs from the end of September to mid-December 2026. The notice does not say whether supply has been interrupted completely or only restricted, and it does not name any alternative products.

The agency directs questions about the current status to the company. The notice is part of DKMA's wider series of announcements on medicine supply.

What it means for your team

  • Veterinary prescribers and poultry health teams in Denmark should check current availability with MSD Animal Health A/S, as DKMA refers status questions to the company.
  • Supply-chain and market-access teams should note the stated window of end September to mid-December 2026 when planning stock.
  • DKMA's notice gives no detail on alternatives or on volumes affected, so contingency planning will depend on information from the marketing company.

Official source: DKMA ↗

Article written by VigiEye from the official source (DKMA). AI-assisted; check the source before acting.

More Quality & compliance All →